Moderna will set up a vaccine manufacturing plant in Laval

Moderna will set up a vaccine manufacturing plant in Laval

MISE À DAY

The biopharmaceutical company Moderna announced Thursday that it has signed a purchase agreement for land in the Laval biotechnology park in order to establish an mRNA vaccine manufacturing plant there.

The contract for the acquisition of this land has been signed with the National Institute for Scientific Research (INRS).

In a press release published Thursday, Moderna considers that this location is ” ideal”.

“This site offers enormous synergy opportunities for Moderna thanks to its proximity to a renowned research institution and corresponds to the requirements of the project and its importance for all Quebecers and Canadians. the company said.

Construction of this biofabrication plant is expected to begin in 2022 and the plant is expected to be operational by the end of 2024, subject to planning and regulatory approvals , we said.

“We look forward to working with the City of Laval, our newest nt partner, in the anticipated implementation of this project and to share more information once the due diligence is completed.”